Investors
KIC Ventures Overview
KIC Ventures is a private equity healthtech investment firm focused on advancing spine surgery innovations and driving the shift of spine procedures from hospitals to outpatient centers. The firm invests in healthcare devices, supplies, manufacturing, and the life sciences sector, with a focus on spine technologies. KIC Ventures innovates, acquires, and incubates groundbreaking technologies that restore natural movement and improve patient outcomes while maintaining majority ownership in its portfolio of differentiated spine companies, ensuring control and direction of innovation. The firm provides research, education, and support for healthcare professionals, empowering them to deliver superior patient care.
AxioMed Overview
As a developer and manufacturer of spinal implants designed for motion-preserving spinal surgery, AxioMed offers groundbreaking solutions with its Freedom Cervical and Lumbar viscoelastic total disc replacement (TDR) technology. These technologies are built to address the limitations of traditional spinal fusion and first-generation disc replacements, restoring the natural biomechanics of the spine, allowing full range of motion, and minimizing the long-term complications associated with spinal fusion. AxioMed is also developing the lateral disc and the AxiomedX Smart Disc, which will provide real-time monitoring of spine biomechanics and patient outcomes. With its own dedicated manufacturing facility for assembling the disc, AxioMed ensures high-quality production standards. Additionally, AxioMed provides education and support for healthcare professionals, empowering them to deliver superior patient outcomes with TDR.
NANISX Overview
NANISX is a wholly owned KIC Ventures portfolio company dedicated to driving innovation in outpatient spine surgery. Its mission is to create, acquire, incubate, and bring to market patented, unique, and essential inventions. By leveraging its proprietary Less Exposure Spine Surgery (LESS) philosophy, NANISX focuses on LESS invasive technologies and techniques that restore and preserve anatomy, reduce recovery times, and empower physicians, supporting the shift of spine procedures from traditional hospital settings to outpatient centers worldwide. As a developer and manufacturer of medical devices designed for spine surgical procedures, NANISX offers a variety of products for LESS invasive spine surgery. The company also provides medical education services, enabling healthcare professionals to improve the efficiency of their treatment and patient outcomes.
Discover Recurring Growth and Impact Investments in Healthcare Technologies with Us: Creating Enduring Company Ownership You Can Pass On
KIC Ventures’ success is built on proven leadership, mitigated risks, and strategic global expansion. With the anticipated 2025 release of AxioMed's lumbar disc replacement to U.S. surgeons, we are poised for accelerated growth, aiming toward a multibillion-dollar valuation.
Our long-term vision as a private equity healthtech investment firm drives our commitment to sustainability in the technologies we acquire for spine surgeons. We acquired AxioMed viscoelastic discs in 2014 not for immediate gains but for their future potential. Similarly, our 2018 acquisition of NanoFuse Biologics underscores our focus on long-term value over short-term profit. While data is essential, we place the highest value on collaboration with our spine colleagues to uncover the truth—a crucial yet often overlooked aspect of our success.
NANISX exemplifies our successful commercialization strategy, showing consistent profitability since 2021 and maintaining a positive EBITDA.
At KIC Ventures, our investment philosophy emphasizes the critical sequence of Team, Technology, and Traction. We focus first on assembling the right team and maintaining fiscal discipline, guiding our technology investments through the prudent reinvestment of portfolio revenues.
Investment Model
Our enduring success is rooted in a strategic approach that combines the astute deployment of founder capital with the valuable partnerships we forge with private investors, including many physicians and patients. This collaborative investment model amplifies our financial reach and integrates 360° diverse insights, enriching our portfolio with a well-rounded perspective
Track Record
Our Visionary Founders Since 2000, Have Been Investing and Leading the Future of Outpatient Spine Surgery Technologies. When You Join Us, Together We Will Build Upon A Legacy That Has Been Transforming Spine Surgery Since We Sold The MANTIS Percutaneous Pedicle Screw System to Stryker (Fortune 500 Company) For A 100x Return On Investment.
The Problem
The current market for low back pain (LBP) management presents a robust investment opportunity, fueled by a rising global prevalence due to the aging population. With LBP affecting approximately 619 million individuals in 2020 and projected to rise to 843 million by 2050, the demand for effective surgical interventions is escalating. US insurance coverage from leading providers grants access to over 150 million people for these therapies, highlighting a significant market potential. A milestone is to treat at least 0.1% (150,000) of the annual global market.
The Market
Analysts project substantial growth in sales of spinal surgery implants, instruments, pharmaceuticals, and novel treatments for chronic back pain, indicating a significant market opportunity to address the $250 billion annual economic cost of chronic back pain, aligning returns with societal impact. 1.The Market: The market for minimally invasive spine surgery is large and growing. 2.The Environment: A fundamental transition from inpatient to outpatient surgery is underway. 3.The Future: Motion and disc replacement are becoming increasingly favored over fixation and fusion.
KIC Ventures partnered with the IRA-Club making it easier for you to invest Tax-Free from your retirement.
Own the Future of Spine Surgery: Invest Confidently in KIC Ventures' to Amplify your Investment Portfolio
Seize the opportunity to become an early investor in KIC Ventures' Series A funding round, aiming to raise $15 million. Our objective is to support the sustained double-digit growth of our NANISX outpatient portfolio and to introduce the eagerly awaited AxioMed viscoelastic disc replacements to the market.
KIC Ventures partnered with the IRA-Club making it easier for you to invest Tax-Free from your retirement.
